Psilocybin, a psychedelic compound, has emerged as a promising treatment for major depressive disorder, particularly for those who have not responded to traditional antidepressants. Studies have shown that psilocybin can lead to rapid and sustained improvement in depressive symptoms, possibly by promoting...
Many spiritual seekers explore the frontiers of the mind, the soul, and reality through the use ofpsychedelic drugssuch as LSD, DMT, psilocybin mushrooms, mescaline, and other entheogens that expand consciousness. While psychoactive substances are a fascinating way of exploring reality, like any othe...
Therapy is a great treatment for generalized anxiety disorder — either on its own or combined with medications. One of the most effective therapies for GAD is cognitive behavioral therapy (CBT). CBT is a type of therapy where you learn to identify, understand, and change your thoughts, feel...
A new mental health treatment using the psychedelic compound psilocybin raises questions about medicine and values
Bright Light Therapy May Help Depression Year-RoundPublished onOctober 4, 2024 depression6 Tips for Better Sleep if You Have DepressionMedically ReviewedbySeth Gillihan, PhD|September 27, 2024 depressionPsilocybin Outperformed a Traditional Antidepressant in a Recent StudyPublished onSeptember 24, 2024 ...
“astronomical amount of space that will inevitably lead to a black market.” Keohane also believes the for-profit clinic model is problematic, pointing to Oregon, where psilocybin therapy is legal and some clinics charge as much as $15,000 for treatment, putting it out of reach for many ...
Psychedelic studies are also proceeding without VA funding, as they have for years, when most of the trials were backed by universities or foundations or other private money. Johns Hopkins University isrecruiting for a studyin which patients would receive psilocybin along with trauma-focused psychothe...
But regulating therapy isn’t part of the FDA’s purview. The FDA approves drugs; it doesn’t oversee how they’re administered. “The agency has been clear with us,” says Kabir Nath, CEO of Compass Pathways, the company working to bring psilocybin to market. “They don’t want to re...
Personality was once thought to be very difficult to alter, but evidence is accumulating that personality can change in adulthood. In a 2011 study, people who took psilocybin, or hallucinogenic "magic mushrooms", became more open after the experience. More recently and in a paper published in ...
Still, psilocybin’s highest accolades have come from the drug’s apparent success in treating depression. Three versions of synthetic psilocybin have received the US Food and Drug Administration’s “breakthrough therapy” designation — in 2018 for treatment-resistant depression, which is diagnosed w...